ACCESSION: MSBNK-SMB_Measured-HSA033P0495005
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; NEGATIVE; Averaged data
DATE: 2025.03.25 (Averaged 2025.02.15, Processed 2025.02.15, Annotated 2025.03.25, Curated 2025.03.25)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Liang et al. J Pharm Biomed Anal. 2022, 214, 114718
COMMENT: This is an averaged mass spectra data created by integrating product ion scan data obtained from the follwing DDA dataset.
COMMENT: DATASET_ID MTBLS3854
COMMENT: DATASET_TITLE Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
COMMENT: DATASET_AUTHORS Xinjun Wang
COMMENT: MS1_M/Z_AVERAGED_THRES 20.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 50
COMMENT: NUM_AVERAGED_SPEC 18
COMMENT: RAW_SPEC {'D171neg_3275': {'bp': 765.0, 'sum': 933.0}, 'D207neg_3294': {'bp': 718.0, 'sum': 1600.0}, 'D108neg_3297': {'bp': 698.0, 'sum': 950.0}, 'C16neg_3132': {'bp': 622.0, 'sum': 874.0}, 'D108neg_3156': {'bp': 607.0, 'sum': 941.0}, 'D102neg_3231': {'bp': 592.0, 'sum': 1179.0}, 'C3neg_3276': {'bp': 590.0, 'sum': 1135.0}, 'D66neg_3301': {'bp': 550.0, 'sum': 676.0}, 'D203neg_3240': {'bp': 503.0, 'sum': 671.0}, 'D168neg_3302': {'bp': 462.0, 'sum': 546.0}, 'D169neg_3210': {'bp': 462.0, 'sum': 755.0}, 'D126neg_3324': {'bp': 458.0, 'sum': 668.0}, 'D102neg_3127': {'bp': 432.0, 'sum': 725.0}, 'D207neg_3253': {'bp': 332.0, 'sum': 416.0}, 'D65neg_3212': {'bp': 332.0, 'sum': 458.0}, 'D124neg_3304': {'bp': 323.0, 'sum': 533.0}, 'D65neg_3291': {'bp': 308.0, 'sum': 350.0}, 'D74neg_3238': {'bp': 271.0, 'sum': 397.0}}
COMMENT: RETENTION_TIME_STDEV 0.050
COMMENT: PRECURSOR_M/Z_RAW 495.295214
COMMENT: PRECURSOR_M/Z_STDEV 0.000923
COMMENT: PRECURSOR_IN_MS1 mz 495.295717; int 15.365; delta(ppm) 1.735730
COMMENT: PROPOSED_CHARGE_STATE -1; mz 496.300105; int 6.415; cor 0.729
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 3
COMMENT: PROPOSED_MF SevenGoldenRules 19.714; C22H50N4O2SP2; [M-H]1; delta(ppm) -19.713756
COMMENT: PROPOSED_MF SevenGoldenRules 18.469; C30H44N2O2S; [M-H]1; delta(ppm) -18.468550
COMMENT: PROPOSED_MF SevenGoldenRules 17.155; C22H48N4O4S2; [M-H]1; delta(ppm) -17.154837
COMMENT: PROPOSED_MF SevenGoldenRules 15.442; C24H53N2S3P; [M-H]1; delta(ppm) -15.442174
COMMENT: PROPOSED_MF SevenGoldenRules 15.404; C21H44N4O9; [M-H]1; delta(ppm) -15.403891
COMMENT: PROPOSED_MF SevenGoldenRules 15.003; C31H45O3P; [M-H]1; delta(ppm) -15.002926
COMMENT: PROPOSED_MF SevenGoldenRules 13.691; C23H49N2O5SP; [M-H]1; delta(ppm) -13.691228
COMMENT: PROPOSED_MF SevenGoldenRules 12.922; C25H46N4O2P2; [M-H]1; delta(ppm) -12.921537
COMMENT: PROPOSED_MF SevenGoldenRules 11.977; C25H54OS2P2; [M-H]1; delta(ppm) -11.976550
COMMENT: PROPOSED_MF SevenGoldenRules 11.676; C33H40N2O2; [M-H]1; delta(ppm) -11.676330
COMMENT: PROPOSED_MF SevenGoldenRules 10.363; C25H44N4O4S; [M-H]1; delta(ppm) -10.362617
COMMENT: PROPOSED_MF SevenGoldenRules 10.226; C24H50O6P2; [M-H]1; delta(ppm) -10.225604
COMMENT: PROPOSED_MF SevenGoldenRules 9.420; C25H52O3S3; [M-H]1; delta(ppm) -9.419645
COMMENT: PROPOSED_MF SevenGoldenRules 8.650; C27H49N2S2P; [M-H]1; delta(ppm) -8.649955
COMMENT: PROPOSED_MF SevenGoldenRules 7.669; C24H48O8S; [M-H]1; delta(ppm) -7.668700
COMMENT: PROPOSED_MF SevenGoldenRules 6.899; C26H45N2O5P; [M-H]1; delta(ppm) -6.899009
COMMENT: PROPOSED_MF SevenGoldenRules 5.184; C28H50OSP2; [M-H]1; delta(ppm) -5.184331
COMMENT: PROPOSED_MF SevenGoldenRules 3.570; C28H40N4O4; [M-H]1; delta(ppm) -3.570398
COMMENT: PROPOSED_MF SevenGoldenRules 2.625; C28H48O3S2; [M-H]1; delta(ppm) -2.625411
COMMENT: PROPOSED_MF SevenGoldenRules 1.856; C30H45N2SP; [M-H]1; delta(ppm) -1.855721
COMMENT: PROPOSED_MF SevenGoldenRules 0.874; C27H44O8; [M-H]1; delta(ppm) -0.874465
COMMENT: PROPOSED_MF SevenGoldenRules 0.544; C22H49N4O2S2P; [M-H]1; delta(ppm) -0.544022
COMMENT: PROPOSED_MF SevenGoldenRules 1.207; C21H45N4O7P; [M-H]1; delta(ppm) 1.206924
COMMENT: PROPOSED_MF SevenGoldenRules 1.608; C31H46OP2; [M-H]1; delta(ppm) 1.607888
COMMENT: PROPOSED_MF SevenGoldenRules 2.922; C23H50N2O3SP2; [M-H]1; delta(ppm) 2.921601
COMMENT: PROPOSED_MF SevenGoldenRules 4.167; C31H44O3S; [M-H]1; delta(ppm) 4.166808
COMMENT: PROPOSED_MF SevenGoldenRules 4.936; C33H41N2P; [M-H]1; delta(ppm) 4.936499
COMMENT: PROPOSED_MF SevenGoldenRules 5.479; C23H48N2O5S2; [M-H]1; delta(ppm) 5.478506
COMMENT: PROPOSED_MF SevenGoldenRules 6.248; C25H45N4O2SP; [M-H]1; delta(ppm) 6.248197
COMMENT: PROPOSED_MF SevenGoldenRules 7.193; C25H53OS3P; [M-H]1; delta(ppm) 7.193184
COMMENT: PROPOSED_MF SevenGoldenRules 7.229; C22H44N2O10; [M-H]1; delta(ppm) 7.229452
COMMENT: PROPOSED_MF SevenGoldenRules 8.944; C24H49O6SP; [M-H]1; delta(ppm) 8.944130
COMMENT: PROPOSED_MF SevenGoldenRules 9.714; C26H46N2O3P2; [M-H]1; delta(ppm) 9.713820
COMMENT: PROPOSED_MF SevenGoldenRules 10.520; C27H48N2S3; [M-H]1; delta(ppm) 10.519779
COMMENT: PROPOSED_MF SevenGoldenRules 10.959; C34H40O3; [M-H]1; delta(ppm) 10.959027
COMMENT: PROPOSED_MF SevenGoldenRules 12.271; C26H44N2O5S; [M-H]1; delta(ppm) 12.270725
COMMENT: PROPOSED_MF SevenGoldenRules 13.040; C28H41N4O2P; [M-H]1; delta(ppm) 13.040416
COMMENT: PROPOSED_MF SevenGoldenRules 13.985; C28H49OS2P; [M-H]1; delta(ppm) 13.985403
COMMENT: PROPOSED_MF SevenGoldenRules 15.335; C17H44N4O12; [M-H]1; delta(ppm) 15.335384
COMMENT: PROPOSED_MF SevenGoldenRules 15.736; C27H45O6P; [M-H]1; delta(ppm) 15.736349
COMMENT: PROPOSED_MF SevenGoldenRules 17.314; C30H44N2S2; [M-H]1; delta(ppm) 17.314013
COMMENT: PROPOSED_MF SevenGoldenRules 17.818; C21H46N4O5P2; [M-H]1; delta(ppm) 17.817738
COMMENT: PROPOSED_MF SevenGoldenRules 18.626; C22H48N4O2S3; [M-H]1; delta(ppm) 18.625712
COMMENT: PROPOSED_MF SevenGoldenRules 19.065; C29H40N2O5; [M-H]1; delta(ppm) 19.064959
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; RRCGNPRHZQPOOT-UHFFFAOYSA-N; C27H44O8; NCGC00385426-01!2,3,14-trihydroxy-10,13-dimethyl-17-(2,3,6,7-tetrahydroxy-6-methylheptan-2-yl)-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
COMMENT: CONFIDENCE Level 5: Exact mass of interest 495.295908; Observed in MS1; Charge state -1;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Plasma
AC$INSTRUMENT: Agilent 1290 liquid chromatography system, Agilent Technologies - TripleTOF 6600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 eV
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 20.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC BEH C18 column (1.7 Âµm, 2.1 mm x 100 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 7.0 min: 65, 8.0 min: 40, 9.0 min: 40, 9.1 min: 95, 12.0 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.5 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 3.533
MS$FOCUSED_ION: PRECURSOR_M/Z 495.295908
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0002-0000900000-f2a75be1741ddb3e9d8e
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  495.2959941 999.0000 ? 495.296351 3.3838 0.00 1.0000 18
PK$NUM_PEAK: 1
PK$PEAK: m/z int. rel.int.
  495.295994 999.00 999
//
